Advertisement
Screener

SPRINGWORKS THERAPEUTICS, INC. Patents: Active

SPRINGWORKS THERAPEUTICS, INC. Active Patents

45 granted patents the USPTO still lists as patented, newest filing first, as the USPTO Open Data Portal records them; the company is the first-named applicant. The application number opens the full record at Patent Center.

  • 2024-10-10: Application 18912218; Invention MIRDAMETINIB TREATMENT; Applicant SpringWorks Therapeutics, Inc.; Status Patented Case.
  • 2024-07-08: Application 18765632; Invention DOSAGE FORMS OF MIRDAMETINIB; Applicant SpringWorks Therapeutics, Inc.; Status Patented Case.
  • 2024-05-24: Application 18674233; Invention MIRDAMETINIB TREATMENT; Applicant Springworks Therapeutics, Inc.; Status Patented Case.
  • 2024-05-24: Application 18674168; Invention MIRDAMETINIB TREATMENT; Applicant SpringWorks Therapeutics, Inc.; Status Patented Case.
FiledApplicationInventionApplicantStatusGrantedPatentPublished asInventor nameInventor countryExaminer
2024-10-1018912218MIRDAMETINIB TREATMENTSpringWorks Therapeutics, Inc.Patented Case2025-08-1912390430
Uchenna H. ILOEJE
Abraham J. LANGSETH
Todd Webster SHEARER
United States
United States
United States
MCKOY, QUINCY ANDRE
2024-07-0818765632DOSAGE FORMS OF MIRDAMETINIBSpringWorks Therapeutics, Inc.Patented Case2025-08-1212383517US20240358661A1
Piero L. RUGGIERO
Kristin PATTERSON
Mark HATCHER
Jiping LIU
Uchenna H. ILOEJE
Abraham J. LANGSETH
United States
United States
United States
United States
United States
United States
HENLEY III, RAYMOND J
2024-05-2418674233MIRDAMETINIB TREATMENTSpringworks Therapeutics, Inc.Patented Case2025-02-1112220390US20240307330A1
Uchenna H. ILOEJE
Abraham J. LANGSETH
Todd Webster SHEARER
United States
United States
United States
LEESER, ERICH A
2024-05-2418674168MIRDAMETINIB TREATMENTSpringWorks Therapeutics, Inc.Patented Case2025-03-2512257215US20240307329A1
Uchenna H. ILOEJE
Abraham J. LANGSETH
Todd Webster SHEARER
United States
United States
United States
LEESER, ERICH A
2024-04-2818648426TREATMENT OF NEUROFIBROMATOSIS TYPE 1 (NF1) ASSOCIATED PLEXIFORM NEUROFIBROMAS (PN) IN PEDIATRIC PATIENTS WITH MIRDAMETINIBSpringWorks Therapeutics, Inc.Patented Case2025-05-1312295925US20250090484A1
Uchenna H. ILOEJE
Abraham J. LANGSETH
Todd SHEARER
United States
United States
United States
DAVIS, BRIAN J
2024-04-0218624670TREATMENTS WITH NIROGACESTATSpringWorks Therapeutics, Inc.Patented Case2024-11-1212138246US20240245648A1
Allison Lim
Shinta Cheng
Todd Webster Shearer
Rex Williams
Kristin Patterson
United States
United States
United States
United States
United States
DAVIS, BRIAN J
2024-03-1918609687MIRDAMETINIB TREATMENTSpringWorks Therapeutics, Inc.Patented Case2026-06-2312661330US20240216305A1
Uchenna H. ILOEJE
Abraham J. LANGSETH
Todd Webster SHEARER
United States
United States
United States
LEESER, ERICH A
2024-03-1818608735DOSAGE FORMS OF MIRDAMETINIBSpringWorks Therapeutics, Inc.Patented Case2024-07-0912029711
Piero L. RUGGIERO
Kristin PATTERSON
Mark HATCHER
Jiping LIU
Uchenna H. ILOEJE
Abraham J. LANGSETH
United States
United States
United States
United States
United States
United States
HENLEY III, RAYMOND J
2024-02-1318440869IMPROVED TREATMENT OF OVARIAN CANCER WITH NIROGACESTATSpringWorks Therapeutics, Inc.Patented Case2026-06-3012667555US20240180874A1
Allison LIM
Shinta CHENG
Todd Webster SHEARER
Rex WILLIAMS
Kristin PATTERSON
United States
United States
United States
United States
United States
DAVIS, BRIAN J
2024-01-3118429056DISPERSIBLE FORMULATIONS OF N-((R)-2,3-DIHYDROXYPROPOXY)-3,4-DIFLUORO-2-(2- FLUORO-4-IODO-PHENYLAMINO)-BENAZMIDE AND USES THEREOFSpringWorks Therapeutics, Inc.Patented Case2024-09-1712090128US20240216307A1
Kristin PATTERSON
Jiping LIU
United States
United States
AZPURU, CARLOS A
2024-01-1618414185TREATMENTS WITH NIROGACESTATSpringWorks Therapeutics, Inc.Patented Case2025-01-0712186305US20240189282A1
Allison LIM
Shinta CHENG
Todd Webster SHEARER
Rex WILLIAMS
Kristin PATTERSON
United States
United States
United States
United States
United States
DAVIS, BRIAN J
2024-01-1618414147TREATMENTS WITH NIROGACESTATSpringWorks Therapeutics, Inc.Patented Case2024-06-1812011435US20240156784A1
Allison LIM
Shinta CHENG
Todd Webster SHEARER
Rex WILLIAMS
Kristin PATTERSON
United States
United States
United States
United States
United States
DAVIS, BRIAN J
2024-01-1618413575CRYSTALLINE SOLIDS OF MEK INHIBITOR N-((R)-2,3-DIHYDROXYPROPOXY)-3,4-DIFLUORO-2-(2-FLUORO-4-IODO--PHENYLAMINO)-BENZAMIDE AND USES THEREOFSpringWorks Therapeutics, Inc.Patented Case2025-04-1512275688US20240190815A1
Kristin PATTERSON
Jiping LIU
Ricky Wayne COUCH
Peter Gregory VARLASHKIN
Mai LI
Yonghong GAN
United States
United States
United States
United States
United States
United States
HENLEY III, RAYMOND J
2023-12-1818543022TREATMENTS WITH NIROGACESTATSpringWorks Therapeutics, Inc.Patented Case2024-07-1612036207US20240148695A1
Allison Lim
Shinta Cheng
Todd Webster Shearer
Rex Williams
Kristin Patterson
United States
United States
United States
United States
United States
DAVIS, BRIAN J
2023-11-2218518127MIRDAMETINIB TREATMENTSpringWorks Therapeutics Inc.Patented Case2025-06-1012324791US20240173274A1
Uchenna H. ILOEJE
Abraham J. LANGSETH
Todd Webster SHEARER
United States
United States
United States
LEESER, ERICH A
2023-10-2018491525TREATMENTS WITH NIROGACESTATSpringWorks Therapeutics, Inc.Patented Case2024-04-0911951096US20240066007A1
Allison Lim
Shinta Cheng
Todd Webster Shearer
Rex Williams
Kristin Patterson
United States
United States
United States
United States
United States
DAVIS, BRIAN J
2023-10-2018491379TREATMENTS WITH NIROGACESTATSpringWorks Therapeutics, Inc.Patented Case2024-04-1611957662US20240050411A1
Allison Lim
Shinta Cheng
Todd Webster Shearer
Rex Williams
Kristin Patterson
United States
United States
United States
United States
United States
DAVIS, BRIAN J
2023-10-2018491323TREATMENTS WITH NIROGACESTATSpringWorks Therapeutics, Inc.Patented Case2024-06-1812011434US20240091197A1
Allison Lim
Shinta Cheng
Todd Webster Shearer
Rex Williams
Kristin Patterson
United States
United States
United States
United States
United States
DAVIS, BRIAN J
2023-10-2018491283TREATMENTS WITH NIROGACESTATSpringWorks Therapeutics, Inc.Patented Case2024-03-2611938116US20240050410A1
Allison Lim
Shinta Cheng
Todd Webster Shearer
Rex Williams
Kristin Patterson
United States
United States
United States
United States
United States
DAVIS, BRIAN J
2023-10-2018491225TREATMENTS WITH NIROGACESTATSpringWorks Therapeutics, Inc.Patented Case2024-03-1211925620US20240058305A1
Allison Lim
Shinta Cheng
Todd Webster Shearer
Rex Williams
Kristin Patterson
United States
United States
United States
United States
United States
DAVIS, BRIAN J
2023-10-2018490993CHLORINATED TETRALIN COMPOUNDS AND PHARMACEUTICAL COMPOSITIONSSpringWorks Therapeutics, Inc.Patented Case2026-04-1412599587US20240058307A1
Kristin PATTERSON
Mark HATCHER
United States
United States
WEDDINGTON, KEVIN E
2023-08-0218364058NON-LINEAR DOSING OF MIRDAMETINIBSpringWorks Therapeutics Inc.Patented Case2025-04-0112263146US20240000731A1
Uchenna H. ILOEJE
Abraham J. LANGSETH
Todd SHEARER
United States
United States
United States
SHIAO, REI TSANG
2023-07-3018361884TREATMENTS WITH NIROGACESTATSpringWorks Therapeutics, Inc.Patented Case2024-03-1211925619US20240033251A1
Allison Lim
Shinta Cheng
Todd Webster Shearer
Rex Williams
Kristin Patterson
United States
United States
United States
United States
United States
DAVIS, BRIAN J
2023-07-2418357988TREATMENT OF NEUROFIBROMATOSIS TYPE 1 (NF1) ASSOCIATED PLEXIFORM NEUROFIBROMAS (PN) IN PEDIATRIC PATIENTS WITH MIRDAMETINIBSpringWorks Therapeutics Inc.Patented Case2024-06-1812011424US20240058282A1
Uchenna H. Iloeje
Abraham J. Langseth
Todd Shearer
United States
United States
United States
DAVIS, BRIAN J
2023-06-1418334518MIRDAMETINIB TREATMENTSpringWorks Therapeutics Inc.Patented Case2024-01-3011883375US20230321014A1
Uchenna H. Iloeje
Abraham J. Langseth
Todd Shearer
United States
United States
United States
LEESER, ERICH A
2023-05-1918320547TREATMENTS WITH NIROGACESTATSpringWorks Therapeutics, Inc.Patented Case2024-01-1611872211US20230372300A1
Allison Lim
Shinta Cheng
Todd Webster Shearer
Rex Williams
Kristin Patterson
United States
United States
United States
United States
United States
DAVIS, BRIAN J
2023-04-2018304202SYNTHESIS OF NIROGACESTATSpringWorks Therapeutics, Inc.Patented Case2025-02-2512234210US20230312480A1
Kristin PATTERSON
Mark HATCHER
United States
United States
HEASLEY, MEGHAN CHRISTINE
2023-04-1718301754CHLORINATED TETRALIN COMPOUNDS AND PHARMACEUTICAL COMPOSITIONSSpringWorks Therapeutics, Inc.Patented Case2023-11-0711807611US20230250065A1
Kristin PATTERSON
Mark HATCHER
United States
United States
WEDDINGTON, KEVIN E
2023-04-1718301742CHLORINATED TETRALIN COMPOUNDS AND PHARMACEUTICAL COMPOSITIONSSpringWorks Therapeutics, Inc.Patented Case2023-12-1911844780US20230310379A1
Kristin PATTERSON
Mark HATCHER
United States
United States
COLEMAN, BRENDA LIBBY
2023-03-2018186312MIRDAMETINIB TREATMENTSpringWorks Therapeutics Inc.Patented Case2023-12-1211839595US20230293466A1
Uchenna H Iloeje
Abraham J Langseth
Todd Shearer
United States
United States
United States
LEESER, ERICH A
2023-03-1618185180Fluorinated Phenylamino Compounds and Pharmaceutical CompositionsSpringWorks Therapeutics Inc.Patented Case2023-10-1011780800US20230295072A1
Kristin Patterson
Piero L Ruggiero
United States
United States
ANDERSON, JAMES D
2023-03-1618185148MIRDAMETINIB TREATMENTSpringWorks Therapeutics Inc.Patented Case2023-11-0711806322US20230321013A1
Uchenna H. Iloeje
Abraham J. Langseth
Todd Shearer
United States
United States
United States
LEESER, ERICH A
2023-03-1618185080TREATMENT OF NEUROFIBROMATOSIS TYPE 1 (NF1) ASSOCIATED PLEXIFORM NEUROFIBROMAS (PN) IN PEDIATRIC PATIENTS WITH MIRDAMETINIBSpringWorks Therapeutics Inc.Patented Case2023-11-2111819487US20230293472A1
Uchenna H Iloeje
Abraham J Langseth
Todd Shearer
United States
United States
United States
DAVIS, BRIAN J
2023-03-1618185045NON-LINEAR DOSING OF MIRDAMETINIBSpringWorks Therapeutics Inc.Patented Case2023-11-0711806321US20230293462A1
Uchenna H. Iloeje
Abraham J. Langseth
Todd Shearer
United States
United States
United States
SHIAO, REI TSANG
2023-01-0918151707DISPERSIBLE FORMULATIONS OF N-((R)-2,3-DIHYDROXYPROPOXY)-3,4-DIFLUORO-2-(2- FLUORO-4-IODO-PHENYLAMINO)-BENAZMIDE AND USES THEREOFSpringWorks Therapeutics, Inc.Patented Case2025-07-1512357597US20230330047A1
Kristin PATTERSON
Jiping LIU
United States
United States
AZPURU, CARLOS A
2022-10-0417937990CHLORINATED TETRALIN COMPOUNDS AND PHARMACEUTICAL COMPOSITIONSSpringWorks Therapeutics, Inc.Patented Case2023-03-2811612588US20230090557A1
Kristin PATTERSON
Mark HATCHER
United States
United States
DRAPER, LESLIE A ROYDS
2022-09-3017937283SYNTHESIS OF NIROGACESTATSPRINGWORKS THERAPEUTICS, INC.Patented Case2025-03-1112247012US20230091415A1
Kristin PATTERSON
Mark HATCHER
United States
United States
JACKSON, SHAWQUIA
2022-09-2917995002CO-ADMINISTRATION OF MIRDAMETINIB AND LIFIRAFENIB FOR USE IN TREATING CANCERSSpringWorks Therapeutics, Inc.
BeiGene, Ltd.
Patented Case2026-06-3012667560US20230128315A1
Lusong LUO
Zhiyu TANG
Badreddin EDRIS
Todd Webster SHEARER
United States
United States
United States
United States
DAVIS, BRIAN J
2022-09-0117929153SYNTHESIS OF NIROGACESTATSPRINGWORKS THERAPEUTICS, INC.Patented Case2024-10-0812110277US20230089434A1
Kristin PATTERSON
Mark HATCHER
United States
United States
SHTERENGARTS, SAMANTHA L
2022-07-0817860682CHLORINATED TETRALIN COMPOUNDS AND PHARMACEUTICAL COMPOSITIONSSpringWorks Therapeutics Inc..Patented Case2022-11-2211504354
Kristin PATTERSON
Mark HATCHER
United States
United States
DRAPER, LESLIE A ROYDS
2022-06-1417806821CRYSTALLINE SOLIDS OF MEK INHIBITOR N-((R)-2,3-DIHYDROXYPROPOXY)-3,4-DIFLUORO-2-(2-FLUORO-4-IODO--PHENYLAMINO)-BENZAMIDE AND USES THEREOFSpringWorks Therapeutics Inc.Patented Case2024-01-3011884610US20230032403A1
Kristin PATTERSON
Jiping LIU
Ricky Wayne COUCH
Peter Gregory VARLASHKIN
Mai LI
Yonghong GAN
United States
United States
United States
United States
United States
United States
HENLEY III, RAYMOND J
2021-10-0817602434COMBINATION THERAPY WITH AN ANTI BCMA ANTIBODY AND A GAMMA SECRETASE INHIBITORSPRINGWORKS THERAPEUTICS, INC.Patented Case2026-03-1012570752US20220168417A1
Swethajit BISWAS
Beata HOLKOVA
Katarina LUPTAKOVA
United Kingdom
United States
United States
O'BRIEN, LEA S
2021-08-0317393144SOLIDS OF MEK INHIBITOR N-((R)-2,3-DIHYDROXYPROPOXY)-3,4-DIFLUORO-2-(2-FLUORO-4-IODO-PHENYLAMINO)-BENZAMIDE AND USES THEREOFSpringWorks Therapeutics Inc.Patented Case2022-08-3011427534US20220267257A1
Kristin PATTERSON
Jiping LIU
Ricky Wayne COUCH
Peter Gregory VARLASHKIN
Mai LI
Yonghong GAN
United States
United States
United States
United States
United States
United States
HENLEY III, RAYMOND J
2021-02-1717177999DISPERSIBLE FORMULATIONS OF N-((R)-2,3-DIHYDROXYPROPOLY)-3,4-DIFLUORO-2-(2-FLUORO-4-IODO-PHENYLAMINO)-BENZAMIDE AND USES THEREOFSpringWorks Therapeutics Inc.Patented Case2023-02-0711571402US20220257543A1
Kristin PATTERSON
Jiping LIU
United States
United States
AZPURU, CARLOS A
2021-02-1717177966CRYSTALLINE SOLIDS OF MEK INHIBITOR N-((R)-2,3-DIHYDROXYPROPOXY)-3,4-DIFLUORO-2-(2-FLUORO-4-IODO-PHENYLAMINO)-BENZAMIDE AND USES THEREOFSpringWorks Therapeutics Inc.Patented Case2021-08-1011084780
Kristin PATTERSON
Jiping LIU
Ricky Wayne COUCH
Peter Gregory VARLASHKIN
Mai LI
Yonghong GAN
United States
United States
United States
United States
United States
United States
HENLEY III, RAYMOND J